[1]刘 周,杭修兵,储雯雯,等.耐碳青霉烯类大肠埃希菌临床分布、耐药特征及携带mcr 基因分析[J].现代检验医学杂志,2022,37(05):1-5+13.[doi:10.3969/j.issn.1671-7414.2022.05.001]
　LIU Zhou,HANG Xiu-bing,CHU Wen-wen,et al.Clinical Distribution, Antimicrobial Agent Resistance and mcr Genes Analysis of Carbapenem-resistant Escherichia coli[J].Journal of Modern Laboratory Medicine,2022,37(05):1-5+13.[doi:10.3969/j.issn.1671-7414.2022.05.001]
点击复制

耐碳青霉烯类大肠埃希菌临床分布、耐药特征及携带mcr 基因分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年05期
页码:
1-5+13
栏目:
论著
出版日期:
2022-09-15

文章信息/Info

Title:
Clinical Distribution, Antimicrobial Agent Resistance and mcr Genes Analysis of Carbapenem-resistant Escherichia coli
文章编号:
1671-7414（2022）05-001-06
作者:
刘 周; 杭修兵; 储雯雯; 李 昕; 姚 杰; 周 强
安徽医科大学第二附属医院检验科，合肥 230601
Author(s):
LIU Zhou;  HANG Xiu-bing;  CHU Wen-wen;  LI Xin;  YAO Jie; ZHOU Qiang
Department of Clinical Laboratory, the Second Hospital of Anhui Medical University, Hefei 230601, China
关键词:
耐碳青霉烯类大肠埃希菌; 新德里金属酶; 多黏菌素B; mcr 基因
分类号:
R378.21；R446.5
DOI:
10.3969/j.issn.1671-7414.2022.05.001
文献标志码:
A
摘要:
目的　分析临床耐碳青霉烯类大肠埃希菌（carbapenem-resistance Escherichia coli , CREC）分布及耐药特征，检测其碳青霉烯酶合成基因及质粒介导的多黏菌素耐药（mobile colistin resistance, mcr）基因携带情况，为多重耐药菌防控提供参考。方法　收集2020 年7 月～ 2021 年6 月期间安徽医科大学第二附属医院住院患者送检的各类临床标本分离非重复CREC 菌株，微量肉汤稀释法进行药敏试验。聚合酶链反应（polymerase chain reaction, PCR）扩增及测序技术检测碳青霉烯酶基因及mcr 系列基因。多黏菌素诱导试验检测mcr-9 阳性菌株的诱导耐药特征，脉冲凝胶电泳（pulsedfieldgel electrophoresis, PFGE）分析其同源性。结果　共收集CREC 菌株33 株，主要分离自尿液标本（30.3%）、痰液标本（24.2%）、脓液/ 分泌物标本（18.2%）及血液标本（15.2%），菌株呈现多重耐药表型。PCR 检测结果显示，23 株CREC（69.7%）携带blaNDM 基因，8 株CREC（24.2%）携带blaKPC 基因。有3 株（9.1%）blaNDM 阳性CREC 菌株同时携带mcr-9 基因，PFGE 分析显示3 株细菌间无同源性。上述mcr-9 阳性菌株经过1/2 倍最低抑菌浓度（minimuminhibitory concentration, MIC）多黏菌素B 药物诱导6h 后，对多黏菌素B 的MIC 值均升高。结论　临床CREC 呈现多重耐药，主要碳青霉烯酶基因为blaNDM 及blaKPC。部分菌株同时携带blaNDM 及mcr-9 基因，且呈现多黏菌素诱导耐药特征。实验室应加强监测，防控其流行播散。
Abstract:
Objective　To analyze the clinical distribution, antimicrobial agent resistance rates of carbapenem resistance Escherichia coli (CREC), and detect the carbapenemse synthesis gene and the carrier of plasmid mediated mobile colistin resistance (MCR) gene, so as to provide reference for the prevention and control of multi-drug resistant bacteria. Methods　Form July 2020 to June 2021, Non-repetitive CREC strains isolated from various clinical specimens submitted by inpatients in the Second Hospital of Anhui Medical University were collected. The antimicrobial susceptibility testing was detected by microbroth dilution method. Carbapenemase encoding and mcr genes were analyzed by PCR amplification and sequencing. The polymyxin B induction assays of mcr-9-positive-isolates were performed, and the homology of mcr-9-positive-isolates was analyzed by pulsed-field gel electrophoresis (PFGE). Results　A total of 33 CREC isolates were collected, which mainly isolated from urine (30.3%), sputum (24.2%), pus/secretion (18.2%) and blood (15.2%), presenting multiple drug resistance phenotypes. 69.7% of the isolates (n=23) harboured blaNDM, while 24.2% of them(n=8) harboured blaKPC. Three CREC isolates (9.1%) carried both blaNDM and mcr-9 genes, and PFGE analysis showed no homology among the three strains. After pretreatment with polymyxins B [1/2×minimum inhibitory concentration (MIC)], the MIC values of mcr-9-positive-strains to polymyxins B were increased. Conclusion　The clinical CREC isolates performed multiple drug resistance phenotype, mainly harboured blaNDM and blaKPC carbapenemase encoding genes. CREC isolates co-harboring blaNDM and mcr-9 were detected, and the polymyxin-induced drug resistance phenotype were detected in all this strains. Laboratory monitoring should be strengthened to prevent and control its spread.

参考文献/References:

[1] SORA V M, MERONI G, MARTINO P A, et al.Extraintestinal pathogenic Escherichia coli: virulence factors and antibiotic resistance[J]. Pathogens, 2021,10(11): 1355.
[2] 徐慧, 徐岷, 刘彩林, 等.2014 ～ 2019 年郑州大学第一附属医院血培养分离病原菌临床分布及耐药性分析[J]. 现代检验医学杂志, 2021, 36(1):136-140.
XU Hui, XU Min, LIU Cailin, et al. Clinical distribution and antibiotic resistance of the blood cultureisolates from the First Affiliated Hospital of Zhengzhou University,2014~2019 [J].Journal of Modern Laboratory Medicine,2021,36(1):136-140.
[3] 全国细菌耐药监测网.全国细菌耐药监测网2014-2019 年不同等级医院细菌耐药监测报告[J].中国感染控制杂志, 2021, 20(2):95-111.
China Antimicrobial Resistance Surveillance System.Surveillance on antimicrobial resistance of bacteria in different levels of hospitals: surveillance report from China Antimicrobial Resistance Surveillance System in 2014-2019 [J]. Chinese Journal of Infection Control,2021, 20(2): 95-111.
[4] 张艳双, 刘静, 万楠, 等.耐碳青霉烯类肠杆菌科(CRE) 耐药分子机制及控制流行的应对策略[J].现代检验医学杂志, 2019, 34(2):1-4.
ZHANG Yanshuang, LIU Jing, WAN Nan, et al.Molecular mechanism of carbapenem-resistant Enterobacteriaceae（CRE） resistance and coping strategies for controlling epidemics [J]. Journal of Modern Laboratory Medicine,2019,34(2):1-4.
[5] LIU Yiyun, WANG Yang, WALSH T R, et al.Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study[J]. The Lancet Infectious Diseases, 2016, 16(2):161-168.
[6] LING Zhuoren, YIN Wenjuan, SHEN Zhangqi, et al. Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9[J]. The Journal of Antimicrobial Chemotherapy, 2020, 75(11): 3087-3095.
[7] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing [S]. 30th ed. Wayne: PA, CLSI supplement M100, 2020.
[8] European Committee on Antimicrobial Susceptibility Testing (EUCAST) .Breakpoint tables for interpretation of MICs and zone diameters (2012)[S].Version10.0,ECAST, 2020. http://www.eucast.org.
[9] DOYLE D, PEIRANO G, LASCOLS C, et al.Laboratory detection of Enterobacteriaceae that produce carbapenemases[J]. Journal of Clinical Microbiology, 2012, 50(12): 3877-3880.
[10] REBELO A R, BORTOLAIA V, KJELDGAARD J S,et al. Multiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposes[J]. Euro Surveillance, 2018, 23(6): 17-00672.
[11] BOROWIAK M, BAUMANN B, FISCHER J, et al.Development of a novel mcr-6 to mcr-9 multiplex PCR and assessment of mcr-1 to mcr-9 occurrence in colistin-resistant Salmonella enterica isolates from Environment, Feed, Animals and Food (2011-2018) in Germany[J].Front Microbiol, 2020 ,11:80.
[12] 刘周, 储雯雯, 李昕, 等.VAP 患者下呼吸道分离CRKP 的临床及分子生物学流行特征[J]. 中国感染控制杂志, 2021, 20(5):403-409.
LIU Zhou, CHU Wenwen, LI Xin, et al. Clinical and molecular epidemiological characteristics of CRKP isolated from lower respiratory tract of patients with ventilator-associated pneumonia [J]. Chinese Journal of Infection Control,2021,20(5):403-409.
[13] NEOH H M, TAN X E, SAPRI H F, et al. Pulsed-field gel electrophoresis (PFGE): A review of the “Gold standard” for bacteria typing and current alternatives[J].Infection Genetics Evolution, 2019, 74: 103935.
[14] KIEFFER N, ROYER G, DECOUSSER J W, et al. Mcr-9, an inducible gene encoding an acquired phosphoethanolamine transferase in Escherichia coli, and its origin[J]. Antimicrobial Agents and Chemotherapy, 2019, 63(9): e00965-19.
[15] ZHANG Rong, LIU Lizhang, ZHOU Hongwei, et al. Nationwide surveillance of clinical carbapenemresistant Enterobacteriaceae (CRE) strains in China[J].EBio Medicine, 2017, 19: 98-106.
[16] USMAN QAMAR M , S LOPES B , HASSAN B, et al.The present danger of New Delhi metallo-β-lactamase:a threat to public health[J]. Future Microbiology, 2021,15(1):1759-1778.
[17] TYSON G H, LI Cong, HSU C H, et al. The mcr-9 gene of salmonella and Escherichia coli is not associated with colistin resistance in the United States[J].Antimicrobial Agents and Chemotherapy, 2020, 64(8):e00573-20.
[18] PAN Yuanlong, FANG Yuan, SONG Xiaofeng, et al. Co-occurrence of mcr-9,extended spectrum betalactamase(ESBL)and AmpC genes in a conjugative IncHI2A plasmid from a multidrug-resistant clinical isolate of Salmonella diarizonae[J]. The Journal of Infection, 2021, 82(4): 84-123.
[19] MACESIC N, BLAKEWAY L V, STEWART J D, et al.Silent spread of Mobile colistin resistance gene mcr-9.1 on IncHI2 “super-plasmids” in clinical carbapenemresistant Enterobacteriales[J]. Clinical Microbiology and Infection, 2021, 27(12): 1856.e7-1856.e13.
[20] 蔡洪流, 姚亚克, 周华.碳青霉烯类抗生素耐药肠杆菌科细菌感染的治疗策略[J].中华临床感染病杂志, 2020, 13(5)：329-334.
CAI Hongliu, YAO Yake, ZHOU Hua. Antimicrobial treatment of carbapenem-resistant Enterobacteriaceae infections [J]. Chinese Journal of Clinical Infectious Diseases, 2020,13(5):329-334.

备注/Memo

备注/Memo:
基金项目： 安徽省自然科学基金项目（1908085QH366），安徽省转化医学研究院科研基金项目（2021zhyx-C47），安徽省高校自然科学研究重大项目（KJ2021ZD0029）。
作者简介：刘周（1984-），男，副主任技师，主要从事细菌耐药机制及分子流行病学研究，E-mail：liuzhou0112@126.com。
通讯作者：周强，主任技师，E-mail：zhouqiang1973@163.com。
更新日期/Last Update: 2022-09-15